Toxic substance abuse during pregnancy;Abuso de sustancias tóxicas durante el embarazo

Medicina Clinica

Volumn 125, Issue 18, 2005, Pages

  Aguilera, Cristina ^a   Izarra, Arguiñe ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CANNABIS; COCAINE; DIAMORPHINE;

ALCOHOL CONSUMPTION; CLINICAL FEATURE; DRUG ABUSE; DRUG DEPENDENCE; FEMALE; HEALTH BEHAVIOR; HUMAN; INTOXICATION; PREGNANCY; SHORT SURVEY; SMOKING; SUBSTANCE ABUSE; TOBACCO;

EID: 29844432251     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(05)72163-1     Document Type: Short Survey

References (33)

1. Consumo de drogas en España. Disponible en http://www.msc.es/pnd/ presenta/html/consumo.htm
2. Martínez-Frías ML. Análisis del riesgo de defectos congénitos debidos a la ingesta de drogas durante el embarazo. Med Clin (Barc). 1999;112:41-4.
3. Hoyme HE, May Pa, Kalberg WO, Kodituwakku P, Gosage Ph, Trujillo PhM, et al. A practical clinical approach to diagnosis of fetal alcohol spectrum disorders: clarification of the 1996 Institute of Medicine Criteria. Pediatrics. 2005;115:39-47.
4. Abel EL. An update on incidence of FAS: FAS is not an equal opportunity birth defect. Neurotoxicol Teratol. 1995;17:437-43.
5. Polygenis D, Wharton S, Malmberg C, Sherman N, Kennedy D, Koren G, et al. Moderate alcohol consumption during pregnancy and the incidence of fetal malformations: A meta-analysis. Neurotoxicol Teratol. 1998;20:61-7.
6. Martínez-Frías M, Bermejo E, Rodríguez-Pinilla E, Fría JL. Risk for congenital anomalies associated with different sporadic and daily doses of alcohol consumption during pregnancy: a case-control study. Birth Defects Res A Clin Mol Teratol. 2004;70:194-200.
7. Sood B, Delayne-Black V, Covington C, Nordstrom-Klee B, Ager J, Templin T, et al. Prenatal alcohol exposure and childhood behavior at age 6 to 7 years: I. Dose-response effect. Pediatrics. 2001;108:34-42.
8. Martínez-Frías ML, Rodríguez-Pinilla E, Bermejo E y Grupo Priférico del ECEMC. Consumo de tabaco durante el embarazo en España: análisis por años, comunidades autónomas y características maternas. Med Clin (Barc). 2005;124:86-92.
9. Källén K. The impact of maternal smoking during pregnancy on delivery outcome. Eur J Public Health. 2001;11:329-33.
10. Alderman BW, Bradley CM, Greene C, Fernbach SK, Baron AE. Increased risk of craniosynostosis with maternal cigarette smoking during pregnancy. Teratology. 1994;50:13-8.
11. Källén K. Maternal smoking and craniosynostosis. Teratology. 1999;60:146-50.
12. Honein MA, Rasmussen SA. Further evidence for an association between maternal smoking and craniosynostosis. Teratology. 2000;62:145-6.
13. Wyszynski DF, Duffy DL, Beaty TH. Maternal cigarette smoking and oral clefts: a meta-analysis. Cleft Palate Craniofac J. 1997;34:206-10.
14. Little J, Cardy A, Munger R. Tobacco smoking and oral clefts: a meta-analysis. Bull World Health Organ. 2004;82:213-8.
15. Skelly AC, Holt VL, Mosca VS, Alderman BW. Talipes equinovarus and maternal smoking: a population-based case-control study in Washington state. Teratology. 2002;66:91-100.
16. De la Chica RA, Ribas I, Giraldo J, Egozcue J, Fuster C. Chromosomal instability in amniocytes from fetuses of mother who smoke. JAMA. 2005;293:1212-22.
17. Torfs CP, Velie EM, Oechsli FW, Bateson TF, Curry CJ. A population-based study of gastroschisis: demographic, pregnancy, and lifestyle risk factors. Teratology. 1994;50:44-53.
18. English DR, Hulse GK, Milne E, Holman CDJ, Bower CI. Maternal cannabis use and birth weight: a meta-analysis. Addiction. 1997;92:1553-60.
19. Fried PA. The Ottawa prenatal prospective study (OPPS): methodological issues and findings- it's easy to throw the baby out with the bath water. Life Scien. 1995;56:2159-68.
20. Smith AM, Fried PA, Hogan MJ, Cameron I. Effects of prenatal marijuana on response inhibition: an fMRI study of young adults. Neurotoxicol Teratology. 2004;26:533-42.
21. Fajemirokun-Odudeyi O, Lindow SW. Obstetric implications of cocaine use in pregnancy: a literature review. Eur J Obstet Gynecol Reprod Biol. 2004;112:2-8.
22. th ed. Philadelphia: Lippincott Williams and Wilkins; 2002.
23. Urogenital anomalies in the offspring of women using cocaine during early pregnancy-Atlanta, 1968-1980. MMWR. Morb Mortal Wkly Rep. 1989;38:536:541-2.
24. Lutiger B, Graham K, Einarson TR, Koren G. Relationship between gestational cocaine use and pregnancy outcome: a meta-analysis. Teratology. 1991;44:405-14.
25. Frank DA, Augustyn M, Knight WG, Pell T, Zuckerman B. Growth, development, and behavior in early childhood following prenatal cocaine exposure. JAMA. 2001;285:1613-25.
26. Addis A, Moretti ME, Syed FA, Einarson TR, Koren G. Fetal effects of cocaine: an update meta-analysis. Reprod Toxicol. 2001;15:341-69.
27. Hulse GK, English DR, Milne E, Holman DJ, Bower CI. Maternal cocaine use and low birth weight newborns: a meta-analysis. Addiction. 1997;92:1561-70.
28. Fares I, McCulloch KM, Raju TN. Intrauterine cocaine exposure and the risk for suden infant death síndrome: a meta-analysis. J Perinatol. 1997;17:179-82.
29. Held JR, Riggs ML, Dorman C. The effect of prenatal cocaine exposure on neurobehavioral outcome: a meta-analysis. Neurotoxicol Teratol. 1999;21:619-25.
30. Lester BM, Tronick EZ, LaGasse L, Seifer R, Bauer ChR, Shankaran S, et al. The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants. Pediatrics. 2002;110:1182-92.
31. Ho E, Karimi-Tabesh L, Koren G. Characteristics of pregnant women who use ecstasy (3,4-methylenedioxymethamphetamine). Neurotoxicol Teratol. 2001;23:561-7.
32. McElhatton PR, Bateman DN, Evans C, Pughe KR, Thomas SH. Congenital anomalies after prenatal ecstasy exposure. Lancet. 1999;354:1441-2.
33. Chang L, Smith LM, LoPresti Ch, Yonekura ML, Kuo J, Walot I, et al. Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Reser Neurol. 2004;132:95-106.